Global Therapeutic Antibody Discovery Platform Supply, Demand and Key Producers, 2023-2029

February 2023 | 116 pages | ID: GEBA3EA72BECEN
GlobalInfoResearch

Abstracts

Antibody discovery platforms have emerged in recent years as an important source of both therapeutic molecules and research reagents.

This report studies the global Therapeutic Antibody Discovery Platform demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Therapeutic Antibody Discovery Platform, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Antibody Discovery Platform that contribute to its increasing demand across many markets.

The global Therapeutic Antibody Discovery Platform market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Highlights and key features of the study

Global Therapeutic Antibody Discovery Platform total market, 2018-2029, (USD Million)

Global Therapeutic Antibody Discovery Platform total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Therapeutic Antibody Discovery Platform total market, key domestic companies and share, (USD Million)

Global Therapeutic Antibody Discovery Platform revenue by player and market share 2018-2023, (USD Million)

Global Therapeutic Antibody Discovery Platform total market by Type, CAGR, 2018-2029, (USD Million)

Global Therapeutic Antibody Discovery Platform total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Therapeutic Antibody Discovery Platform market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abveris, YUMAB, Ablexis, AvantGen, OXGENE, Evotec, Alacrita, Invetx and Charles River Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Antibody Discovery Platform market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Therapeutic Antibody Discovery Platform Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Therapeutic Antibody Discovery Platform Market, Segmentation by Type

• Animal
• Human

Global Therapeutic Antibody Discovery Platform Market, Segmentation by Application

• Pharmaceutical and Biotechnology Companies
• Research Laboratories

Companies Profiled:

• Abveris
• YUMAB
• Ablexis
• AvantGen
• OXGENE
• Evotec
• Alacrita
• Invetx
• Charles River Laboratories
• Aerium Therapeutics
• Chugai Pharmaceutical
• AbCellera
• Twist Bioscience
• Talem Therapeutics
• Bio-Rad
• Memo Therapeutics
• OmniAb
• Antibody Solutions
• Lepu Biopharma

Key Questions Answered

1. How big is the global Therapeutic Antibody Discovery Platform market?

2. What is the demand of the global Therapeutic Antibody Discovery Platform market?

3. What is the year over year growth of the global Therapeutic Antibody Discovery Platform market?

4. What is the total value of the global Therapeutic Antibody Discovery Platform market?

5. Who are the major players in the global Therapeutic Antibody Discovery Platform market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Therapeutic Antibody Discovery Platform Introduction
1.2 World Therapeutic Antibody Discovery Platform Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Therapeutic Antibody Discovery Platform Total Market by Region (by Headquarter Location)
  1.3.1 World Therapeutic Antibody Discovery Platform Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Therapeutic Antibody Discovery Platform Market Size (2018-2029)
  1.3.3 China Therapeutic Antibody Discovery Platform Market Size (2018-2029)
  1.3.4 Europe Therapeutic Antibody Discovery Platform Market Size (2018-2029)
  1.3.5 Japan Therapeutic Antibody Discovery Platform Market Size (2018-2029)
  1.3.6 South Korea Therapeutic Antibody Discovery Platform Market Size (2018-2029)
  1.3.7 ASEAN Therapeutic Antibody Discovery Platform Market Size (2018-2029)
  1.3.8 India Therapeutic Antibody Discovery Platform Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Therapeutic Antibody Discovery Platform Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Therapeutic Antibody Discovery Platform Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)
2.2 World Therapeutic Antibody Discovery Platform Consumption Value by Region
  2.2.1 World Therapeutic Antibody Discovery Platform Consumption Value by Region (2018-2023)
  2.2.2 World Therapeutic Antibody Discovery Platform Consumption Value Forecast by Region (2024-2029)
2.3 United States Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)
2.4 China Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)
2.5 Europe Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)
2.6 Japan Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)
2.7 South Korea Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)
2.8 ASEAN Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)
2.9 India Therapeutic Antibody Discovery Platform Consumption Value (2018-2029)

3 WORLD THERAPEUTIC ANTIBODY DISCOVERY PLATFORM COMPANIES COMPETITIVE ANALYSIS

3.1 World Therapeutic Antibody Discovery Platform Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Therapeutic Antibody Discovery Platform Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Therapeutic Antibody Discovery Platform in 2022
  3.2.3 Global Concentration Ratios (CR8) for Therapeutic Antibody Discovery Platform in 2022
3.3 Therapeutic Antibody Discovery Platform Company Evaluation Quadrant
3.4 Therapeutic Antibody Discovery Platform Market: Overall Company Footprint Analysis
  3.4.1 Therapeutic Antibody Discovery Platform Market: Region Footprint
  3.4.2 Therapeutic Antibody Discovery Platform Market: Company Product Type Footprint
  3.4.3 Therapeutic Antibody Discovery Platform Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Therapeutic Antibody Discovery Platform Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Therapeutic Antibody Discovery Platform Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Therapeutic Antibody Discovery Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Therapeutic Antibody Discovery Platform Consumption Value Comparison
  4.2.1 United States VS China: Therapeutic Antibody Discovery Platform Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Therapeutic Antibody Discovery Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Therapeutic Antibody Discovery Platform Companies and Market Share, 2018-2023
  4.3.1 United States Based Therapeutic Antibody Discovery Platform Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Therapeutic Antibody Discovery Platform Revenue, (2018-2023)
4.4 China Based Companies Therapeutic Antibody Discovery Platform Revenue and Market Share, 2018-2023
  4.4.1 China Based Therapeutic Antibody Discovery Platform Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Therapeutic Antibody Discovery Platform Revenue, (2018-2023)
4.5 Rest of World Based Therapeutic Antibody Discovery Platform Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Therapeutic Antibody Discovery Platform Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Therapeutic Antibody Discovery Platform Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Therapeutic Antibody Discovery Platform Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Animal
  5.2.2 Human
5.3 Market Segment by Type
  5.3.1 World Therapeutic Antibody Discovery Platform Market Size by Type (2018-2023)
  5.3.2 World Therapeutic Antibody Discovery Platform Market Size by Type (2024-2029)
  5.3.3 World Therapeutic Antibody Discovery Platform Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Therapeutic Antibody Discovery Platform Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Pharmaceutical and Biotechnology Companies
  6.2.2 Research Laboratories
6.3 Market Segment by Application
  6.3.1 World Therapeutic Antibody Discovery Platform Market Size by Application (2018-2023)
  6.3.2 World Therapeutic Antibody Discovery Platform Market Size by Application (2024-2029)
  6.3.3 World Therapeutic Antibody Discovery Platform Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Abveris
  7.1.1 Abveris Details
  7.1.2 Abveris Major Business
  7.1.3 Abveris Therapeutic Antibody Discovery Platform Product and Services
  7.1.4 Abveris Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Abveris Recent Developments/Updates
  7.1.6 Abveris Competitive Strengths & Weaknesses
7.2 YUMAB
  7.2.1 YUMAB Details
  7.2.2 YUMAB Major Business
  7.2.3 YUMAB Therapeutic Antibody Discovery Platform Product and Services
  7.2.4 YUMAB Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 YUMAB Recent Developments/Updates
  7.2.6 YUMAB Competitive Strengths & Weaknesses
7.3 Ablexis
  7.3.1 Ablexis Details
  7.3.2 Ablexis Major Business
  7.3.3 Ablexis Therapeutic Antibody Discovery Platform Product and Services
  7.3.4 Ablexis Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Ablexis Recent Developments/Updates
  7.3.6 Ablexis Competitive Strengths & Weaknesses
7.4 AvantGen
  7.4.1 AvantGen Details
  7.4.2 AvantGen Major Business
  7.4.3 AvantGen Therapeutic Antibody Discovery Platform Product and Services
  7.4.4 AvantGen Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 AvantGen Recent Developments/Updates
  7.4.6 AvantGen Competitive Strengths & Weaknesses
7.5 OXGENE
  7.5.1 OXGENE Details
  7.5.2 OXGENE Major Business
  7.5.3 OXGENE Therapeutic Antibody Discovery Platform Product and Services
  7.5.4 OXGENE Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 OXGENE Recent Developments/Updates
  7.5.6 OXGENE Competitive Strengths & Weaknesses
7.6 Evotec
  7.6.1 Evotec Details
  7.6.2 Evotec Major Business
  7.6.3 Evotec Therapeutic Antibody Discovery Platform Product and Services
  7.6.4 Evotec Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Evotec Recent Developments/Updates
  7.6.6 Evotec Competitive Strengths & Weaknesses
7.7 Alacrita
  7.7.1 Alacrita Details
  7.7.2 Alacrita Major Business
  7.7.3 Alacrita Therapeutic Antibody Discovery Platform Product and Services
  7.7.4 Alacrita Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Alacrita Recent Developments/Updates
  7.7.6 Alacrita Competitive Strengths & Weaknesses
7.8 Invetx
  7.8.1 Invetx Details
  7.8.2 Invetx Major Business
  7.8.3 Invetx Therapeutic Antibody Discovery Platform Product and Services
  7.8.4 Invetx Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Invetx Recent Developments/Updates
  7.8.6 Invetx Competitive Strengths & Weaknesses
7.9 Charles River Laboratories
  7.9.1 Charles River Laboratories Details
  7.9.2 Charles River Laboratories Major Business
  7.9.3 Charles River Laboratories Therapeutic Antibody Discovery Platform Product and Services
  7.9.4 Charles River Laboratories Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Charles River Laboratories Recent Developments/Updates
  7.9.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.10 Aerium Therapeutics
  7.10.1 Aerium Therapeutics Details
  7.10.2 Aerium Therapeutics Major Business
  7.10.3 Aerium Therapeutics Therapeutic Antibody Discovery Platform Product and Services
  7.10.4 Aerium Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Aerium Therapeutics Recent Developments/Updates
  7.10.6 Aerium Therapeutics Competitive Strengths & Weaknesses
7.11 Chugai Pharmaceutical
  7.11.1 Chugai Pharmaceutical Details
  7.11.2 Chugai Pharmaceutical Major Business
  7.11.3 Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Product and Services
  7.11.4 Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Chugai Pharmaceutical Recent Developments/Updates
  7.11.6 Chugai Pharmaceutical Competitive Strengths & Weaknesses
7.12 AbCellera
  7.12.1 AbCellera Details
  7.12.2 AbCellera Major Business
  7.12.3 AbCellera Therapeutic Antibody Discovery Platform Product and Services
  7.12.4 AbCellera Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 AbCellera Recent Developments/Updates
  7.12.6 AbCellera Competitive Strengths & Weaknesses
7.13 Twist Bioscience
  7.13.1 Twist Bioscience Details
  7.13.2 Twist Bioscience Major Business
  7.13.3 Twist Bioscience Therapeutic Antibody Discovery Platform Product and Services
  7.13.4 Twist Bioscience Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Twist Bioscience Recent Developments/Updates
  7.13.6 Twist Bioscience Competitive Strengths & Weaknesses
7.14 Talem Therapeutics
  7.14.1 Talem Therapeutics Details
  7.14.2 Talem Therapeutics Major Business
  7.14.3 Talem Therapeutics Therapeutic Antibody Discovery Platform Product and Services
  7.14.4 Talem Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Talem Therapeutics Recent Developments/Updates
  7.14.6 Talem Therapeutics Competitive Strengths & Weaknesses
7.15 Bio-Rad
  7.15.1 Bio-Rad Details
  7.15.2 Bio-Rad Major Business
  7.15.3 Bio-Rad Therapeutic Antibody Discovery Platform Product and Services
  7.15.4 Bio-Rad Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Bio-Rad Recent Developments/Updates
  7.15.6 Bio-Rad Competitive Strengths & Weaknesses
7.16 Memo Therapeutics
  7.16.1 Memo Therapeutics Details
  7.16.2 Memo Therapeutics Major Business
  7.16.3 Memo Therapeutics Therapeutic Antibody Discovery Platform Product and Services
  7.16.4 Memo Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.16.5 Memo Therapeutics Recent Developments/Updates
  7.16.6 Memo Therapeutics Competitive Strengths & Weaknesses
7.17 OmniAb
  7.17.1 OmniAb Details
  7.17.2 OmniAb Major Business
  7.17.3 OmniAb Therapeutic Antibody Discovery Platform Product and Services
  7.17.4 OmniAb Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.17.5 OmniAb Recent Developments/Updates
  7.17.6 OmniAb Competitive Strengths & Weaknesses
7.18 Antibody Solutions
  7.18.1 Antibody Solutions Details
  7.18.2 Antibody Solutions Major Business
  7.18.3 Antibody Solutions Therapeutic Antibody Discovery Platform Product and Services
  7.18.4 Antibody Solutions Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.18.5 Antibody Solutions Recent Developments/Updates
  7.18.6 Antibody Solutions Competitive Strengths & Weaknesses
7.19 Lepu Biopharma
  7.19.1 Lepu Biopharma Details
  7.19.2 Lepu Biopharma Major Business
  7.19.3 Lepu Biopharma Therapeutic Antibody Discovery Platform Product and Services
  7.19.4 Lepu Biopharma Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023)
  7.19.5 Lepu Biopharma Recent Developments/Updates
  7.19.6 Lepu Biopharma Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Therapeutic Antibody Discovery Platform Industry Chain
8.2 Therapeutic Antibody Discovery Platform Upstream Analysis
8.3 Therapeutic Antibody Discovery Platform Midstream Analysis
8.4 Therapeutic Antibody Discovery Platform Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Therapeutic Antibody Discovery Platform Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Therapeutic Antibody Discovery Platform Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Therapeutic Antibody Discovery Platform Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Therapeutic Antibody Discovery Platform Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Therapeutic Antibody Discovery Platform Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Therapeutic Antibody Discovery Platform Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Therapeutic Antibody Discovery Platform Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Therapeutic Antibody Discovery Platform Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Therapeutic Antibody Discovery Platform Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Therapeutic Antibody Discovery Platform Players in 2022
Table 12. World Therapeutic Antibody Discovery Platform Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Therapeutic Antibody Discovery Platform Company Evaluation Quadrant
Table 14. Head Office of Key Therapeutic Antibody Discovery Platform Player
Table 15. Therapeutic Antibody Discovery Platform Market: Company Product Type Footprint
Table 16. Therapeutic Antibody Discovery Platform Market: Company Product Application Footprint
Table 17. Therapeutic Antibody Discovery Platform Mergers & Acquisitions Activity
Table 18. United States VS China Therapeutic Antibody Discovery Platform Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Therapeutic Antibody Discovery Platform Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Therapeutic Antibody Discovery Platform Companies, Headquarters (States, Country)
Table 21. United States Based Companies Therapeutic Antibody Discovery Platform Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Therapeutic Antibody Discovery Platform Revenue Market Share (2018-2023)
Table 23. China Based Therapeutic Antibody Discovery Platform Companies, Headquarters (Province, Country)
Table 24. China Based Companies Therapeutic Antibody Discovery Platform Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Therapeutic Antibody Discovery Platform Revenue Market Share (2018-2023)
Table 26. Rest of World Based Therapeutic Antibody Discovery Platform Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Therapeutic Antibody Discovery Platform Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Therapeutic Antibody Discovery Platform Revenue Market Share (2018-2023)
Table 29. World Therapeutic Antibody Discovery Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Therapeutic Antibody Discovery Platform Market Size by Type (2018-2023) & (USD Million)
Table 31. World Therapeutic Antibody Discovery Platform Market Size by Type (2024-2029) & (USD Million)
Table 32. World Therapeutic Antibody Discovery Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Therapeutic Antibody Discovery Platform Market Size by Application (2018-2023) & (USD Million)
Table 34. World Therapeutic Antibody Discovery Platform Market Size by Application (2024-2029) & (USD Million)
Table 35. Abveris Basic Information, Area Served and Competitors
Table 36. Abveris Major Business
Table 37. Abveris Therapeutic Antibody Discovery Platform Product and Services
Table 38. Abveris Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Abveris Recent Developments/Updates
Table 40. Abveris Competitive Strengths & Weaknesses
Table 41. YUMAB Basic Information, Area Served and Competitors
Table 42. YUMAB Major Business
Table 43. YUMAB Therapeutic Antibody Discovery Platform Product and Services
Table 44. YUMAB Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. YUMAB Recent Developments/Updates
Table 46. YUMAB Competitive Strengths & Weaknesses
Table 47. Ablexis Basic Information, Area Served and Competitors
Table 48. Ablexis Major Business
Table 49. Ablexis Therapeutic Antibody Discovery Platform Product and Services
Table 50. Ablexis Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Ablexis Recent Developments/Updates
Table 52. Ablexis Competitive Strengths & Weaknesses
Table 53. AvantGen Basic Information, Area Served and Competitors
Table 54. AvantGen Major Business
Table 55. AvantGen Therapeutic Antibody Discovery Platform Product and Services
Table 56. AvantGen Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AvantGen Recent Developments/Updates
Table 58. AvantGen Competitive Strengths & Weaknesses
Table 59. OXGENE Basic Information, Area Served and Competitors
Table 60. OXGENE Major Business
Table 61. OXGENE Therapeutic Antibody Discovery Platform Product and Services
Table 62. OXGENE Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. OXGENE Recent Developments/Updates
Table 64. OXGENE Competitive Strengths & Weaknesses
Table 65. Evotec Basic Information, Area Served and Competitors
Table 66. Evotec Major Business
Table 67. Evotec Therapeutic Antibody Discovery Platform Product and Services
Table 68. Evotec Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Evotec Recent Developments/Updates
Table 70. Evotec Competitive Strengths & Weaknesses
Table 71. Alacrita Basic Information, Area Served and Competitors
Table 72. Alacrita Major Business
Table 73. Alacrita Therapeutic Antibody Discovery Platform Product and Services
Table 74. Alacrita Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Alacrita Recent Developments/Updates
Table 76. Alacrita Competitive Strengths & Weaknesses
Table 77. Invetx Basic Information, Area Served and Competitors
Table 78. Invetx Major Business
Table 79. Invetx Therapeutic Antibody Discovery Platform Product and Services
Table 80. Invetx Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Invetx Recent Developments/Updates
Table 82. Invetx Competitive Strengths & Weaknesses
Table 83. Charles River Laboratories Basic Information, Area Served and Competitors
Table 84. Charles River Laboratories Major Business
Table 85. Charles River Laboratories Therapeutic Antibody Discovery Platform Product and Services
Table 86. Charles River Laboratories Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Charles River Laboratories Recent Developments/Updates
Table 88. Charles River Laboratories Competitive Strengths & Weaknesses
Table 89. Aerium Therapeutics Basic Information, Area Served and Competitors
Table 90. Aerium Therapeutics Major Business
Table 91. Aerium Therapeutics Therapeutic Antibody Discovery Platform Product and Services
Table 92. Aerium Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Aerium Therapeutics Recent Developments/Updates
Table 94. Aerium Therapeutics Competitive Strengths & Weaknesses
Table 95. Chugai Pharmaceutical Basic Information, Area Served and Competitors
Table 96. Chugai Pharmaceutical Major Business
Table 97. Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Product and Services
Table 98. Chugai Pharmaceutical Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Chugai Pharmaceutical Recent Developments/Updates
Table 100. Chugai Pharmaceutical Competitive Strengths & Weaknesses
Table 101. AbCellera Basic Information, Area Served and Competitors
Table 102. AbCellera Major Business
Table 103. AbCellera Therapeutic Antibody Discovery Platform Product and Services
Table 104. AbCellera Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. AbCellera Recent Developments/Updates
Table 106. AbCellera Competitive Strengths & Weaknesses
Table 107. Twist Bioscience Basic Information, Area Served and Competitors
Table 108. Twist Bioscience Major Business
Table 109. Twist Bioscience Therapeutic Antibody Discovery Platform Product and Services
Table 110. Twist Bioscience Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Twist Bioscience Recent Developments/Updates
Table 112. Twist Bioscience Competitive Strengths & Weaknesses
Table 113. Talem Therapeutics Basic Information, Area Served and Competitors
Table 114. Talem Therapeutics Major Business
Table 115. Talem Therapeutics Therapeutic Antibody Discovery Platform Product and Services
Table 116. Talem Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Talem Therapeutics Recent Developments/Updates
Table 118. Talem Therapeutics Competitive Strengths & Weaknesses
Table 119. Bio-Rad Basic Information, Area Served and Competitors
Table 120. Bio-Rad Major Business
Table 121. Bio-Rad Therapeutic Antibody Discovery Platform Product and Services
Table 122. Bio-Rad Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Bio-Rad Recent Developments/Updates
Table 124. Bio-Rad Competitive Strengths & Weaknesses
Table 125. Memo Therapeutics Basic Information, Area Served and Competitors
Table 126. Memo Therapeutics Major Business
Table 127. Memo Therapeutics Therapeutic Antibody Discovery Platform Product and Services
Table 128. Memo Therapeutics Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Memo Therapeutics Recent Developments/Updates
Table 130. Memo Therapeutics Competitive Strengths & Weaknesses
Table 131. OmniAb Basic Information, Area Served and Competitors
Table 132. OmniAb Major Business
Table 133. OmniAb Therapeutic Antibody Discovery Platform Product and Services
Table 134. OmniAb Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. OmniAb Recent Developments/Updates
Table 136. OmniAb Competitive Strengths & Weaknesses
Table 137. Antibody Solutions Basic Information, Area Served and Competitors
Table 138. Antibody Solutions Major Business
Table 139. Antibody Solutions Therapeutic Antibody Discovery Platform Product and Services
Table 140. Antibody Solutions Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Antibody Solutions Recent Developments/Updates
Table 142. Lepu Biopharma Basic Information, Area Served and Competitors
Table 143. Lepu Biopharma Major Business
Table 144. Lepu Biopharma Therapeutic Antibody Discovery Platform Product and Services
Table 145. Lepu Biopharma Therapeutic Antibody Discovery Platform Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 146. Global Key Players of Therapeutic Antibody Discovery Platform Upstream (Raw Materials)
Table 147. Therapeutic Antibody Discovery Platform Typical Customers
List of Figure
Figure 1. Therapeutic Antibody Discovery Platform Picture
Figure 2. World Therapeutic Antibody Discovery Platform Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Therapeutic Antibody Discovery Platform Total Market Size (2018-2029) & (USD Million)
Figure 4. World Therapeutic Antibody Discovery Platform Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Therapeutic Antibody Discovery Platform Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Therapeutic Antibody Discovery Platform Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Therapeutic Antibody Discovery Platform Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Therapeutic Antibody Discovery Platform Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Therapeutic Antibody Discovery Platform Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Therapeutic Antibody Discovery Platform Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Therapeutic Antibody Discovery Platform Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Therapeutic Antibody Discovery Platform Revenue (2018-2029) & (USD Million)
Figure 13. Therapeutic Antibody Discovery Platform Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 16. World Therapeutic Antibody Discovery Platform Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 18. China Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 23. India Therapeutic Antibody Discovery Platform Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Therapeutic Antibody Discovery Platform by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Therapeutic Antibody Discovery Platform Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Therapeutic Antibody Discovery Platform Markets in 2022
Figure 27. United States VS China: Therapeutic Antibody Discovery Platform Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Therapeutic Antibody Discovery Platform Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Therapeutic Antibody Discovery Platform Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Therapeutic Antibody Discovery Platform Market Size Market Share by Type in 2022
Figure 31. Animal
Figure 32. Human
Figure 33. World Therapeutic Antibody Discovery Platform Market Size Market Share by Type (2018-2029)
Figure 34. World Therapeutic Antibody Discovery Platform Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Therapeutic Antibody Discovery Platform Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical and Biotechnology Companies
Figure 37. Research Laboratories
Figure 38. Therapeutic Antibody Discovery Platform Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source